The for-cause termination and clawback of severance signals potential governance issues beyond the disclosed matter. Watch for any subsequent legal action by the company or Bonick, and monitor for any further disclosures regarding internal controls or executive compensation practices.
Price Chart
Executive Summary
Ardent Health's Board recharacterized former CEO Martin Bonick's departure as a termination for Cause, citing failure to disclose third-party compensation. The company will discontinue approximately $4.5 million in unpaid cash severance and cancel all outstanding unvested performance-based restricted stock units. No financial restatement is required.
Key Facts
- Former CEO Martin Bonick's separation was recharacterized as a termination for Cause effective June 2, 2026.
- Board determined Bonick failed to fully disclose compensation received from third parties as required by company policies.
- Company will discontinue approximately $4.5 million of unpaid cash severance.
- All outstanding unvested performance-based restricted stock units (PRSUs) will be cancelled/forfeited.
- Company reserved rights to pursue other remedies against Bonick.
- No financial statements or previously disclosed financial results require revision or correction.
Financial Impact
Approximately $4.5 million in unpaid cash severance discontinued; unvested PRSUs cancelled (value not disclosed).
Risk Factors
- Potential litigation from former CEO over for-cause determination.
- Reputational damage to corporate governance reputation.
- Possible further internal control weaknesses may emerge.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-118499 |
| Document: 0001104659-26-118499-index-headers.html | 0001104659-26-118499 |
| Document: 0001104659-26-118499-index.html | 0001104659-26-118499 |
| Document: 0001104659-26-118499.txt | 0001104659-26-118499 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 8-K | $12.18 $11.83 | ▲ +2.87% | ▲ +3.43% | $11.83 (+2.87%) |
Aug 20, 2026 9w ago | 144 | $10.99 $11.25 | ▲ +2.37% | ▲ +2.66% | $11.83 (+7.64%) |
Aug 15, 2026 10w ago | Institutional Cluster | $10.89 $10.93 | ▲ +0.37% | ▲ +1.04% | $11.83 (+8.63%) |
Jun 30, 2026 17w ago | 8-K | $10.13 $10.76 | ▲ +6.22% | ▲ +6.35% | $11.83 (+16.78%) |
Jun 11, 2026 19w ago | Institutional Cluster | $9.67 $9.35 | ▼ −3.31% | ▼ −3.85% | $11.83 (+22.34%) |
Jun 2, 2026 21w ago | 8-K | $7.83 $8.60 | ▲ +9.83% | ▲ +9.43% | $11.83 (+51.09%) |
May 5, 2026 25w ago | 8-K | $9.37 $9.37 | · 0.00% | ▲ +0.33% | $11.83 (+26.25%) |
Apr 8, 2026 28w ago | DEFA14A | $9.53 $9.40 | ▼ −1.36% | ▼ −1.30% | $11.83 (+24.13%) |
Mar 4, 2026 33w ago | 8-K | $9.44 $8.90 | ▼ −5.72% | ▼ −4.41% | $11.83 (+25.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers